AUSTRALIA – CSL Ltd, an Australian biopharmaceutical company, has agreed to acquire Vifor Pharma AG for US$11.7 billion (equity value) in order to diversify its business. CSL has made an…
Read MoreCSL seals US$11.7 billion cash buyout deal of Vifor Pharma
